Luo and coworkers have recently shown that STC1 levels directly correlate with those of matrix metalloproteinases (MMP)-2, MMP9, and vimentin in gliomas, and these authors hypothesized that STC1 augments the invasive capacities of glioma cells (49). The gene discussed is MMP2; the disease is glioma.